A preferably or O O

• Rh (D) +ve patients may receive Rh (D) +ve or Rh (D) -ve products.

• Rh (D) -ve patients should receive Rh (D) -ve platelets.

• Occasionally necessary to give Rh (D) +ve platelets to Rh (D) -ve patients. The Blood Bank should be informed as all future red cell transfusions must be Rh (D) -ve. Anti-D administration may be given to such patients routinely or may be reserved for women of child-bearing age (dose: 250iu (50|jg). Anti-D SC immediately after the transfusion.

0 0

Post a comment